Published in Zentralbl Bakteriol on November 01, 1998
Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci U S A (2010) 3.05
Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics. PLoS One (2010) 1.89
Panton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model. PLoS One (2011) 1.22
Rapid detection of Staphylococcus aureus Panton-Valentine leukocidin in clinical specimens by enzyme-linked immunosorbent assay and immunochromatographic tests. J Clin Microbiol (2010) 1.03
The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes. Clin Exp Immunol (2009) 0.98
A histidine-to-arginine substitution in Panton-Valentine leukocidin from USA300 community-acquired methicillin-resistant Staphylococcus aureus does not impair its leukotoxicity. Infect Immun (2009) 0.89
Variability of antibiotic susceptibility and toxin production of Staphylococcus aureus strains isolated from skin, soft tissue, and bone related infections. BMC Microbiol (2013) 0.84
Role of pore-forming toxins in neonatal sepsis. Clin Dev Immunol (2013) 0.78
Random amplified polymorphic DNA assay is less discriminant than pulsed-field gel electrophoresis for typing strains of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1993) 3.21
Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun (1995) 3.08
Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis (1989) 2.25
Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol (1995) 2.25
Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology (1992) 2.13
High interlaboratory reproducibility of matrix-assisted laser desorption ionization-time of flight mass spectrometry-based species identification of nonfermenting bacteria. J Clin Microbiol (2009) 2.13
Prevalence of Bartonella henselae and Bartonella clarridgeiae in stray cats. J Clin Microbiol (1997) 2.11
Pseudocoagulase activity of staphylococci. J Clin Microbiol (1979) 2.10
Species identities and antimicrobial susceptibilities of corynebacteria isolated from various clinical sources. Eur J Clin Microbiol Infect Dis (1996) 2.07
Detection of Legionella spp. in bronchoalveolar lavage fluids by DNA amplification. J Clin Microbiol (1992) 2.03
Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study. Arch Intern Med (1996) 1.98
Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis (1995) 1.97
Bartonella tribocorum sp. nov., a new Bartonella species isolated from the blood of wild rats. Int J Syst Bacteriol (1998) 1.97
Phylogeny of the genus Corynebacterium deduced from analyses of small-subunit ribosomal DNA sequences. Int J Syst Bacteriol (1995) 1.90
Bartonella alsatica sp. nov., a new Bartonella species isolated from the blood of wild rabbits. Int J Syst Bacteriol (1999) 1.87
Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family. FEBS Lett (1998) 1.81
Nocardia pseudobrasiliensis sp. nov., a new species of Nocardia which groups bacterial strains previously identified as Nocardia brasiliensis and associated with invasive diseases. Int J Syst Bacteriol (1996) 1.74
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry identifies 90% of bacteria directly from blood culture vials. Clin Microbiol Infect (2010) 1.73
Prevalence of types of Diplococcus pneumoniae and their susceptibility to 30 antibiotics. Chemotherapy (1970) 1.72
Leukocidal toxins of staphylococci. Zentralbl Bakteriol (1999) 1.68
Detection of Borrelia burgdorferi DNA in muscle of patients with chronic myalgia related to Lyme disease. Am J Med (1998) 1.66
Genomic diversity and phylogenetic relationships among lipid-requiring diphtheroids from humans and characterization of Corynebacterium macginleyi sp. nov. Int J Syst Bacteriol (1995) 1.65
Genomic diversity among Corynebacterium jeikeium strains and comparison with biochemical characteristics and antimicrobial susceptibilities. J Clin Microbiol (1994) 1.64
Staphylococcal clumping with soluble fibrin mmonomer complexes. J Exp Med (1967) 1.59
Staphylococcal pore-forming toxins. Curr Top Microbiol Immunol (2001) 1.55
High-performance liquid chromatography of antibiotics. J Chromatogr (1990) 1.52
Pore formation by a two-component leukocidin from Staphylococcus aureus within the membrane of human polymorphonuclear leukocytes. Biochim Biophys Acta (1993) 1.51
Investigation on extracellular slime substance produced by Staphylococcus epidermidis. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 1.49
Improved purification of leukocidin from Staphylococcus aureus and toxin distribution among hospital strains. Res Microbiol (1991) 1.48
The structure of a Staphylococcus aureus leucocidin component (LukF-PV) reveals the fold of the water-soluble species of a family of transmembrane pore-forming toxins. Structure (1999) 1.45
Assessment of the role of gamma-toxin in experimental endophthalmitis using a hlg-deficient mutant of Staphylococcus aureus. Microb Pathog (1998) 1.40
Ion channels and bacterial infection: the case of beta-barrel pore-forming protein toxins of Staphylococcus aureus. FEBS Lett (2003) 1.37
Taxonomy of Corynebacterium diphtheriae and related taxa, with recognition of Corynebacterium ulcerans sp. nov. nom. rev. FEMS Microbiol Lett (1995) 1.36
The structure of Staphylococcus aureus epidermolytic toxin A, an atypic serine protease, at 1.7 A resolution. Structure (1997) 1.34
Characterisation of a synergohymenotropic toxin produced by Staphylococcus intermedius. FEBS Lett (1995) 1.34
Flow cytometric determination of Panton-Valentine leucocidin S component binding. Infect Immun (2001) 1.34
Bacteremia due to Gordona sputi in an immunocompromised patient. J Clin Microbiol (1996) 1.34
Leukotriene B4 generation and DNA fragmentation induced by leukocidin from Staphylococcus aureus: protective role of granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF for human neutrophils. Infect Immun (1994) 1.32
The interaction of Staphylococcus aureus bi-component gamma-hemolysins and leucocidins with cells and lipid membranes. Biochim Biophys Acta (1998) 1.31
A new purification procedure for Clostridium difficile enterotoxin. Biochem Biophys Res Commun (1984) 1.27
Bartonella birtlesii sp. nov., isolated from small mammals (Apodemus spp.). Int J Syst Evol Microbiol (2000) 1.27
Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-lukD. J Clin Microbiol (1999) 1.26
Corynebacterium argentoratense sp. nov., from the human throat. Int J Syst Bacteriol (1995) 1.26
Frequency of isolation of Staphylococcus intermedius from humans. J Clin Microbiol (1997) 1.26
Taxonomic study of Corynebacterium Group ANF-1 strains: Proposal of Corynebacterium afermentans sp. nov. containing the subspecies C. afermentans subsp. afermentans subsp. nov. and C. afermentans subsp. lipophilum subsp. nov. Int J Syst Bacteriol (1993) 1.26
Mode of action of beta-barrel pore-forming toxins of the staphylococcal alpha-hemolysin family. Toxicon (2001) 1.25
O and H serotyping of Pseudomonas cepacia. J Clin Microbiol (1983) 1.24
Peripartum bacteremias due to Leptotrichia amnionii and Sneathia sanguinegens, rare causes of fever during and after delivery. J Clin Microbiol (2004) 1.24
Purification and some properties of the staphylococcal extracellular lipase. Biochim Biophys Acta (1983) 1.22
Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study. Arch Dermatol (1994) 1.22
Antibiotics and immunomodulation: effects of cefotaxime, amikacin, mezlocillin, piperacillin and clindamycin. Med Microbiol Immunol (1985) 1.19
Hospital routine analysis of penicillins, third-generation cephalosporins and aztreonam by conventional and high-speed high-performance liquid chromatography. J Chromatogr (1987) 1.17
[Phenotype characteristics of 100 strains of Pseudomonas cepacia. Proposition of a biovars classification (author's transl)]. Ann Biol Clin (Paris) (1981) 1.15
Application of flow cytometry in toxinology: pathophysiology of human polymorphonuclear leukocytes damaged by a pore-forming toxin from Staphylococcus aureus. Cytometry (1995) 1.12
Channel-forming leucotoxins from Staphylococcus aureus cause severe inflammatory reactions in a rabbit eye model. J Med Microbiol (1997) 1.11
The staphylococcal pore-forming leukotoxins open Ca2+ channels in the membrane of human polymorphonuclear neutrophils. J Membr Biol (1998) 1.11
Discoupling the Ca(2+)-activation from the pore-forming function of the bi-component Panton-Valentine leucocidin in human PMNs. FEBS Lett (1999) 1.11
Corynebacterium seminale sp. nov., a new species associated with genital infections in male patients. J Clin Microbiol (1995) 1.11
Reaction of rabbit leucocytes to staphylococcal (Panton-Valentine) leucocidin in vivo. J Pathol Bacteriol (1966) 1.11
Staphylococcus aureus isolated in cases of impetigo produces both epidermolysin A or B and LukE-LukD in 78% of 131 retrospective and prospective cases. J Clin Microbiol (2001) 1.07
Variable expressions of Staphylococcus aureus bicomponent leucotoxins semiquantified by competitive reverse transcription-PCR. Appl Environ Microbiol (2000) 1.07
Direct molecular typing of Borrelia burgdorferi sensu lato species in synovial samples from patients with lyme arthritis. J Clin Microbiol (2000) 1.07
The nature of clotting and fibrinolytic activities of Bacteroids melaninogenicus. Zentralbl Bakteriol Orig A (1978) 1.06
A new case of Wolbachia dependence in the genus Asobara: evidence for parthenogenesis induction in Asobara japonica. Heredity (Edinb) (2009) 1.05
Identification of Mycobacterium shimoidei in a tuberculosis-like cavity by 16S ribosomal DNA direct sequencing. Eur J Clin Microbiol Infect Dis (1996) 1.04
Evaluation of the applicability of amplified rDNA-restriction analysis (ARDRA) to identification of species of the genus Corynebacterium. Res Microbiol (1995) 1.03
Comparison of high-pressure liquid chromatography and microbiological assay for the determination of biliary elimination of ciprofloxacin in humans. Antimicrob Agents Chemother (1985) 1.03
Prothrombin activation by a metalloprotease from Staphylococcus aureus. J Clin Microbiol (1980) 1.03
HPLC quantitation of the six main components of teicoplanin in biological fluids. J Antimicrob Chemother (1988) 1.02
Assessment of biliary excretion of piperacillin-tazobactam in humans. Antimicrob Agents Chemother (1997) 1.02
Corynebacterium singulare sp. nov., a new species for urease-positive strains related to Corynebacterium minutissimum. Int J Syst Bacteriol (1997) 1.02
Campylobacter lari bacteremia. Clin Microbiol Infect (2001) 1.01
Comparative study of immunological properties and cytotoxic effects of Clostridium difficile toxin B and Clostridium sordellii toxin L. Toxicon (1992) 1.01
Enzyme-linked immunosorbent assays for Staphylococcus aureus exfoliative toxins A and B and some applications. J Clin Microbiol (1984) 1.00
[Isolation, identification and clinical significance of species of the Flavobacterium genus]. Ann Biol Clin (Paris) (1983) 1.00